The Fenway Institute Epidemiology Team Launches LITE Plus Transgender Health Study
LITE Plus is a longitudinal study that will be exploring the health disparities of racial minority transgender women to assess the impact of stigma-related chronic
Fenway Health Closed Monday, January 20 for Martin Luther King, Jr. Day
All Fenway Health locations and programs, including The Fenway Institute, AIDS Action, and the Borum, will be closed Monday, January 20 for Martin Luther King,
New Paper Provides Blueprint for Building Transgender Health Programs in Primary Care Settings
BOSTON, JANUARY 13, 2020—A paper published today in Annals of Family Medicine provides a concise and practical guide for physicians and others managing primary care
Fenway Health Board of Directors Now Accepting Applications for Term beginning on July 1, 2020
The Board of Directors supports the work of Fenway Health and provides mission based leadership and governance. Although day-to-day operations are the responsibility of Fenway’s
Dr. Sari Reisner Named BWH Director of Transgender Research
We are pleased to announce that Brigham and Women’s Hospital has appointed Sari L. Reisner, Sc.D. as Director of Transgender Research in the Section of
2019 Winter Holiday Hours
All Fenway Health locations, including the Borum and AIDS Action, will be closed December 25 for Christmas and January 1 for New Year’s Day. We
Introducing the next CEO of Fenway Health, Ellen LaPointe
On behalf of the Fenway Health Board of Directors, I am thrilled to announce the selection of Ellen LaPointe, an experienced and dynamic leader, as
Ellen LaPointe is named Chief Executive Officer of Fenway Health
BOSTON, MA – The Board of Directors of Fenway Health announced today that it has selected Ellen LaPointe to be its next Chief Executive Officer.